RU2019108189A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019108189A3 RU2019108189A3 RU2019108189A RU2019108189A RU2019108189A3 RU 2019108189 A3 RU2019108189 A3 RU 2019108189A3 RU 2019108189 A RU2019108189 A RU 2019108189A RU 2019108189 A RU2019108189 A RU 2019108189A RU 2019108189 A3 RU2019108189 A3 RU 2019108189A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610700714 | 2016-08-22 | ||
| CN201610700714.2 | 2016-08-22 | ||
| PCT/CN2017/098461 WO2018036469A1 (zh) | 2016-08-22 | 2017-08-22 | Pde4抑制剂 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| RU2019108189A3 true RU2019108189A3 (ru) | 2020-09-22 |
| RU2019108189A RU2019108189A (ru) | 2020-09-22 |
| RU2743126C2 RU2743126C2 (ru) | 2021-02-15 |
| RU2743126C9 RU2743126C9 (ru) | 2021-04-27 |
Family
ID=61246401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019108189A RU2743126C9 (ru) | 2016-08-22 | 2017-08-22 | Ингибитор pde4 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10662189B2 (ru) |
| EP (1) | EP3502111B1 (ru) |
| JP (1) | JP7029444B2 (ru) |
| CN (1) | CN109661395B (ru) |
| AU (1) | AU2017317123B9 (ru) |
| CA (1) | CA3034785C (ru) |
| RU (1) | RU2743126C9 (ru) |
| WO (1) | WO2018036469A1 (ru) |
| ZA (1) | ZA201901773B (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3747884B1 (en) * | 2018-01-29 | 2022-11-02 | Medshine Discovery Inc. | Crystal form of 1h-imidazo[4,5-b]pyridine-2(3h)-one compound and preparation method therefor |
| BR112021004730A2 (pt) * | 2018-09-13 | 2021-06-01 | Kissei Pharmaceutical Co., Ltd. | composto de imidazopiridinona |
| CN115397819A (zh) * | 2020-02-24 | 2022-11-25 | 苏州隆博泰药业有限公司 | Pde4抑制剂化合物及其医药用途 |
| JP7504822B2 (ja) * | 2020-03-12 | 2024-06-24 | キッセイ薬品工業株式会社 | イミダゾピリジノン化合物を含む医薬組成物 |
| CN112876403B (zh) * | 2021-01-27 | 2022-10-21 | 成都摩尔生物医药有限公司 | 一种阿普斯特杂质的制备方法 |
| EP4326713A4 (en) * | 2021-04-12 | 2025-03-19 | Impact Therapeutics (Shanghai), Inc. | Substituted fused bicyclic compounds as parp inhibitors and the use thereof |
| CN119161297A (zh) * | 2024-09-18 | 2024-12-20 | 浙江工业大学 | 一种4-溴-6-氯烟酸甲酯的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667316B1 (en) * | 1999-11-12 | 2003-12-23 | Celgene Corporation | Pharmaceutically active isoindoline derivatives |
| BRPI0519030A2 (pt) | 2004-12-13 | 2008-12-23 | Celgene Corp | mÉtodos de tratamento, prevenÇço, ou controle de inflamaÇço das vias aÉreas e de uma doenÇa ou distérbio das vias aÉreas ou pulmonar, e, composiÇço farmacÊutica |
| ES2347172T3 (es) | 2005-02-16 | 2010-10-26 | Astrazeneca Ab | Compuestos quimicos. |
| CN101119996A (zh) * | 2005-02-16 | 2008-02-06 | 阿斯利康(瑞典)有限公司 | 化学化合物 |
| GB0525143D0 (en) * | 2005-12-09 | 2006-01-18 | Novartis Ag | Organic compounds |
| MX2009004077A (es) | 2006-10-19 | 2009-05-05 | Signal Pharm Llc | Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas. |
| JP5662319B2 (ja) * | 2008-09-09 | 2015-01-28 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アザ−ベンゾイミダゾロンキマーゼ阻害剤 |
| WO2011021678A1 (ja) | 2009-08-21 | 2011-02-24 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| WO2015175956A1 (en) * | 2014-05-16 | 2015-11-19 | Celgene Corporation | Compositions and methods for the treatment of atherosclerotic cardiovascular diseases with pde4 modulators |
-
2017
- 2017-08-22 WO PCT/CN2017/098461 patent/WO2018036469A1/zh not_active Ceased
- 2017-08-22 US US16/326,976 patent/US10662189B2/en active Active
- 2017-08-22 JP JP2019510953A patent/JP7029444B2/ja active Active
- 2017-08-22 CN CN201780051434.6A patent/CN109661395B/zh active Active
- 2017-08-22 AU AU2017317123A patent/AU2017317123B9/en active Active
- 2017-08-22 RU RU2019108189A patent/RU2743126C9/ru active
- 2017-08-22 CA CA3034785A patent/CA3034785C/en active Active
- 2017-08-22 EP EP17842892.6A patent/EP3502111B1/en active Active
-
2019
- 2019-03-22 ZA ZA2019/01773A patent/ZA201901773B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3502111B1 (en) | 2022-07-27 |
| EP3502111A1 (en) | 2019-06-26 |
| US10662189B2 (en) | 2020-05-26 |
| ZA201901773B (en) | 2021-08-25 |
| JP7029444B2 (ja) | 2022-04-07 |
| AU2017317123B9 (en) | 2021-11-25 |
| AU2017317123A1 (en) | 2019-04-11 |
| CN109661395B (zh) | 2020-09-01 |
| EP3502111A4 (en) | 2020-05-20 |
| WO2018036469A1 (zh) | 2018-03-01 |
| CA3034785C (en) | 2022-11-15 |
| AU2017317123B2 (en) | 2021-07-29 |
| CA3034785A1 (en) | 2018-03-01 |
| RU2743126C2 (ru) | 2021-02-15 |
| US20190177318A1 (en) | 2019-06-13 |
| RU2743126C9 (ru) | 2021-04-27 |
| RU2019108189A (ru) | 2020-09-22 |
| JP2019528298A (ja) | 2019-10-10 |
| CN109661395A (zh) | 2019-04-19 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TH4A | Reissue of patent specification | ||
| PC41 | Official registration of the transfer of exclusive right |
Effective date: 20210830 |